|
4/2018
vol. 17
abstract:
Original paper
Effects of six weeks of resistance-endurance training on microRNA-29 expression in the heart of ovariectomised rats
Morteza Jourkesh, Rahman Soori, Conrad P. Earnest, Lamia Mirheidari, Ali Asghar Ravasi, Stephen R. Stannard, Matias Monsalves-Alvarez
Menopause Rev 2018; 17(4): 155-160
Online publish date: 2019/01/30
Introduction
Heart disease risk rises with age. However, women’s symptoms become more pronounced following the onset of menopause. The aim of the present study was to evaluate the effects of six weeks of combined resistance-endurance (RE) training on microRNA-29 expression in the heart of ovariectomised rats.
Material and methods
Thirty female Wistar rats were divided into three groups: 1) sham (SHAM); 2) ovariectomy (OVX); and 3) OVX with RE training (OVX + RE). The effects of these treatments on cardiac microRNA-29 expression were measured using real-time PCR. Data were analysed using a 2 × 3 ANOVA and Tukey post-hoc comparisons and presented as mean ±SEM.
Results
Ovariectomy resulted in a significant down-regulation in the heart microRNA-29 gene expression of OVX (0.265 ±0.031 fold changes), OVX + RE (0.699 ±0.038 fold changes) in animals vs. sham animals (1 ±0 fold changes; all, p < 0.05) following six weeks of treatment. However, microRNA-29 expression in the OVX + RE group was significantly greater than in the OVX group (p < 0.05).
Conclusions
Our findings suggest that the six weeks of regular RE training attenuate the reduction in heart muscle microRNA-29 expression observed in ovariectomised rates. If our findings carry over to humans, such an exercise regimen could be beneficial to the cardiovascular disease risk in women during menopause.
keywords:
ovariectomy, exercise training, microRNA-29, cardiac
references:
Rivera CM, Grossardt BR, Rhodes DJ, et al. Increased cardiovascular mortality following early bilateral oophorectomy. Menopause 2009; 16: 15-23.
Stampfer MJ, Colditz GA. Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence. Prev Med 1991; 20: 47-63.
Mendelsohn ME, Karas RH. The protective effects of estrogen on cardiovascular system. N Engl J Med 1999; 340: 1801-1111.
Scuteri A, Ferrucci L. Blood pressure, arterial function, structure, and aging: the role of hormonal replacement therapy in postmenopausal women. J Clin Hypertens 2003; 5: 219-225.
Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trial. JAMA 2002; 288: 321-333.
Yager JD, Davidson NE. Estrogen carcinogenesis in breast cancer. N Engl J Med 2006; 354: 270-282.
Burkman RT, Collins JA, Greene RA. Current perspectives on benefits and risks of hormone replacement therapy. Am J Obstet Gynecol 2001; 185: S13-S23.
Silva GJJ, Bye A, El Azzouzi H, Wisløff U. MicroRNAs as Important Regulators of Exercise Adaptation. Prog Cardiovasc Dis 2017; 60: 130-151.
Al-Nakkash L, Martin JB, Petty D, et al. Dietary genistein induces sex-dependent effects on murine body weight, serum profiles, and vascular function of thoracic aortae. Gender Med 2012; 9: 295-308.
Moreira JB, Bechara LR, Bozi LH, et al. High- versus moderate-intensity aerobic exercise training effects on skeletal muscle of infarcted rats. J Appl Physiol 2013; 114: 1029-1041.
Messina M. Soy foods, isoflavones, and the health of postmenopausal women. Am J Clin Nutr 2014; 100 (Suppl): 423S-430S.
Maturana MA, Irigoyen MC, Spritzer PM. Menopause, estrogens, and endothelial dysfunction: current concepts. Clinics 2007; 62: 77-86.
Friedenreich CM. Physical activity and breast cancer risk: the effect of menopausal status. Exerc Sport Sci Rev 2004; 32: 180-184.
Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 1993; 75: 843-854.
Soci UP, Fernandes T, Hashimoto NY, et al. MicroRNAs 29 are involved in the improvement of ventricular compliance promoted by aerobic exercise training in rats. Physiol Genomics 2011; 43: 665-673.
Davidsen PK, Gallagher IJ, Hartman JW, et al. High responders to resistance exercise training demonstrate differential regulation of skeletal muscle microRNA expression. J Appl Physiol 2011; 110: 309-317.
Da Silva Jr ND, Fernandes T, Soci UP, et al. Swimming training in rats increases cardiac microRNA-126 expression and angiogenesis. Med Sci Sports Exerc 2012; 44: 1453-1462.
Radom-Aizik S, Zaldivar Jr FP, Haddad F, Cooper DM. Impact of brief exercise on circulating monocyte gene and microRNA expression: implications for atherosclerotic vascular disease. Brain Behav Immun 2014; 39: 121-129.
Van Eickels M, Grohé C, Cleutjens JP, et al. 17-Estradiol attenuates the development of pressure-overload hypertrophy. Circulation 2001; 104: 1419-1423.
Leptidis S, El Azzouzi H, Lok SI, et al. A deep sequencing approach to uncover the miRNOME in the human heart. PLoS One 2013; 8: e57800.
Van Rooij E, Sutherland LB, Thatcher JE, et al. Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis. Proc Natl Acad Sci U S A 2008; 105: 13027-13032.
Roderburg C, Urban GW, Bettermann K, et al. Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis. Hepatology 2011; 53: 209-218.
Wang B, Komers R, Carew R, et al. Suppression of microRNA-29 expression by TGF-beta1 promotes collagen expression and renal fibrosis. J Am Soc Nephrol 2012; 23: 252-265.
Cushing L, Kuang PP, Qian J, et al. miR-29 is a major regulator of genes associated with pulmonary fibrosis. Am J Respir Cell Mol Biol 2011; 45: 287-294.
Jourkesh M, Choobineh S, Soori R, Ravasi AA. Effect of combined endurance-resistance training and soy extract supplementation on expression of eNOS gene in rats. Arch Med Sci Atheroscler Dis 2017; 2: e76-e81.
Oh HY, Lim S, Lee JM, et al. A combination of soy isoflavone supplementation and exercise improves lipid profiles and protects antioxidant defense-systems against exercise-induced oxidative stress in ovariectomized rats. Biofactors 2007; 29: 175-185.
Habibi P, Alihemmati AR, Nour Azar AR, et al. Expression of the Mir-133 and Bcl-2 could be affected by swimming training in the heart of ovariectomized rats. Iran J Basic Med Sci 2016; 19: 381-387.
Jin L, Hyung SC, Dae YK, et al. Combined effects of exercise and soy isoflavone diet on paraoxonase, nitric oxide and aortic apoptosis in ovariectomized rats. Appetite 2012; 58: 462-469.
Melton SA, Hegsted M, Keenan MJ, et al. Swimming eliminates the weight gain and abdominal fat associated with ovariectomy in the retired breeder rat despite high-fat diet selection. Appetite 2000; 35: 1-7.
Habibi P, Alihemmati AR, Nasirzadeh MR, et al. Involvement of microRNA-133 and -29 in cardiac disturbances in diabetic ovariectomized rats. Iran J Basic Med Sci 2016; 19: 1177-1185.
Hamilton KL, Lin L, Wang Y, Knowlton AA. Effect of ovariectomy on cardiac gene expression: inflammation and changes in SOCS gene expression. Physiol Genomics 2008; 32: 254-263.
Abbate A, Bussani R, Amin MS, et al. Acute myocardial infarction and heart failure: role of apoptosis. Int J Biochem Cell Biol 2006; 38: 1834-1840.
Maric C. Risk factors for cardiovascular disease in women with diabetes. Gender Med 2010; 7: 551.
Liou CM, Yang AL, Kuo CH, et al. Effects of 17beta-estradiol on cardiac apoptosis in ovariectomized rats. Cell Biochem Funct 2010; 28: 521-528.
Webster KA, Graham RM, Thompson JW, et al. Bishopric NH. Redox stress and the contributions of BH3-only proteins to infarction. Antioxid Redox Signal 2006; 8: 1667-1676.
Ikeda S, Kong SW, Lu J, et al. Altered microRNA expression in human heart disease. Physiol Genomics 2007; 31: 367-373.
Thum T, Galuppo P, Wolf C, et al. MicroRNAs in the human heart: a clue to fetal gene reprogramming in heart failure. Circulation 2007; 116: 258-267.
Matkovich SJ, Van Booven DJ, Youker KA, et al. Reciprocal regulation of myocardial microRNAs and messenger RNA in human cardiomyopathy and reversal of the microRNA signature by biomechanical support. Circulation 2009; 119: 1263-1271.
Bonci D. MicroRNA-21 as therapeutic target in cancer and cardiovascular disease. Recent patents on cardiovascular drug discovery 2010; 5: 156-161.
Lacey JV, Mink Jr PJ, Lubin JH, et al. Menopausal hormone replacement therapy and risk of ovarian cancer. JAMA 2002; 288: 334-341.
Roncarati R, Viviani Anselmi C, Losi MA, et al. Circulating miR-29a, among other up-regulated microRNAs, is the only biomarker for both hypertrophy and fibrosis in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 2014; 63: 920-927.
Melo SF, Fernandes T, Barauna VG, et al. Expression of microRNA-29 and collagen in cardiac muscle after swimming training in myocardial-infarcted rats. Cell Physiol Biochem 2014; 33: 657-669.
Ban CR, Twigg SM. Fibrosis in diabetes complications: pathogenic mechanisms and circulating and urinary markers. Vasc Health Risk Manag 2008; 4: 575.
Neri Serneri GG, Boddi M, Modesti PA, et al. Increased cardiac sympathetic activity and insulin-like growth factor-I formation are associated with physiological hypertrophy in athletes. Circ Res 2001; 89: 977-982.
Fuller SJ, Mynett JR, Sugden PH. Stimulation of cardiac protein synthesis by insulin-like growth-factors. Biochem J 1992; 282: 85-90.
Habibi P, Alihemmatti A, Alipour M, et al. Effect of exercise on mir-29 and IGF-1 expression and lipid profile in the heart of ovariectomized rats. Acta Endocrinol 2016; 2: 130-136.
Van Rooij E, Sutherland LB, Thatcher JE, et al. Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis. Proc Natl Acad Sci U S A 2008; 105: 13027-13032.
|
|
